Literature DB >> 28516116

ASC-particle-induced Peritonitis.

Lucia de Almeida1, Andrea Dorfleutner1, Christian Stehlik1.   

Abstract

In response to pathogen infection and tissue damage, inflammasome sensors such as NLRP3 and AIM2 are activated, which triggers PYRIN domain (PYD)-mediated ASC nucleation, followed by self-perpetuating ASC polymerization, which ultimately culminates in caspase-1 activation, interleukin (IL)-1β and IL-18 processing and release and pyroptosis (Ratsimandresy et al., 2013; Cai et al., 2014). Inflammasomes release not only cytokines, but also the polymeric ASC danger particles (pASC) by pyroptosis, which perpetuate and propagate inflammasome responses to bystander cells to engage cell intrinsic ASC and caspase-1 (Baroja-Mazo et al., 2014; Franklin et al., 2014). In this protocol we describe intraperitoneal injection of polymeric ASC particles as a danger signal and measure neutrophil infiltration and levels of the pro-inflammatory cytokine IL-1β by ELISA in the peritoneal lavage (de Almeida et al., 2015).

Entities:  

Year:  2016        PMID: 28516116      PMCID: PMC5431586          DOI: 10.21769/BioProtoc.1944

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  9 in total

1.  Use of nanodiamond particles for rapid isolation of recombinant apoobelin from Escherichia coli.

Authors:  V S Bondar'; A P Puzyr'
Journal:  Dokl Biochem       Date:  2000 Jul-Aug

2.  The pyroptosome: a supramolecular assembly of ASC dimers mediating inflammatory cell death via caspase-1 activation.

Authors:  T Fernandes-Alnemri; J Wu; J-W Yu; P Datta; B Miller; W Jankowski; S Rosenberg; J Zhang; E S Alnemri
Journal:  Cell Death Differ       Date:  2007-06-29       Impact factor: 15.828

3.  Assembly, purification, and assay of the activity of the ASC pyroptosome.

Authors:  Teresa Fernandes-Alnemri; Emad S Alnemri
Journal:  Methods Enzymol       Date:  2008       Impact factor: 1.600

4.  The NLRP3 inflammasome is released as a particulate danger signal that amplifies the inflammatory response.

Authors:  Alberto Baroja-Mazo; Fatima Martín-Sánchez; Ana I Gomez; Carlos M Martínez; Joaquín Amores-Iniesta; Vincent Compan; Maria Barberà-Cremades; Jordi Yagüe; Estibaliz Ruiz-Ortiz; Jordi Antón; Segundo Buján; Isabelle Couillin; David Brough; Juan I Arostegui; Pablo Pelegrín
Journal:  Nat Immunol       Date:  2014-06-22       Impact factor: 25.606

5.  Prion-like polymerization underlies signal transduction in antiviral immune defense and inflammasome activation.

Authors:  Xin Cai; Jueqi Chen; Hui Xu; Siqi Liu; Qiu-Xing Jiang; Randal Halfmann; Zhijian J Chen
Journal:  Cell       Date:  2014-03-13       Impact factor: 41.582

6.  Isolation of Particles of Recombinant ASC and NLRP3.

Authors:  Fátima Martín-Sánchez; Ana I Gómez; Pablo Pelegrín
Journal:  Bio Protoc       Date:  2015-05-20

7.  The PYRIN Domain-only Protein POP1 Inhibits Inflammasome Assembly and Ameliorates Inflammatory Disease.

Authors:  Lucia de Almeida; Sonal Khare; Alexander V Misharin; Rajul Patel; Rojo A Ratsimandresy; Melissa C Wallin; Harris Perlman; David R Greaves; Hal M Hoffman; Andrea Dorfleutner; Christian Stehlik
Journal:  Immunity       Date:  2015-08-11       Impact factor: 31.745

Review 8.  An Update on PYRIN Domain-Containing Pattern Recognition Receptors: From Immunity to Pathology.

Authors:  Rojo A Ratsimandresy; Andrea Dorfleutner; Christian Stehlik
Journal:  Front Immunol       Date:  2013-12-09       Impact factor: 7.561

9.  The adaptor ASC has extracellular and 'prionoid' activities that propagate inflammation.

Authors:  Bernardo S Franklin; Lukas Bossaller; Dominic De Nardo; Jacqueline M Ratter; Andrea Stutz; Gudrun Engels; Christoph Brenker; Mark Nordhoff; Sandra R Mirandola; Ashraf Al-Amoudi; Matthew S Mangan; Sebastian Zimmer; Brian G Monks; Martin Fricke; Reinhold E Schmidt; Terje Espevik; Bernadette Jones; Andrew G Jarnicki; Philip M Hansbro; Patricia Busto; Ann Marshak-Rothstein; Simone Hornemann; Adriano Aguzzi; Wolfgang Kastenmüller; Eicke Latz
Journal:  Nat Immunol       Date:  2014-06-22       Impact factor: 25.606

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.